Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Liminal BioSciences Inc. LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Recent & Breaking News (NDAQ:LMNL)

Liminal BioSciences Announces Upcoming Presentations for Ryplazim® (plasminogen) at the 62nd ASH Annual Meeting and Exposition

Canada NewsWire November 5, 2020

Liminal BioSciences Announces Private Placement Financing of USD$30 Million

Canada NewsWire October 30, 2020

Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®(plasminogen)

Canada NewsWire September 21, 2020

Liminal BioSciences to Present at The H.C. Wainwright 22nd Annual Global Investment Conference

Canada NewsWire September 9, 2020

Liminal BioSciences Announces Resubmission of Biologics License Application to U.S. Food and Drug Administration for Ryplazim® (plasminogen) for Treatment of Congenital Plasminogen Deficiency

PR Newswire September 8, 2020

Liminal BioSciences Announces New Appointments to its Board of Directors

Canada NewsWire September 1, 2020

Liminal BioSciences reports financial results for Q2-2020

Canada NewsWire August 10, 2020

Liminal Biosciences to Present at Canaccord 40th Annual Growth Conference

Canada NewsWire August 6, 2020

Liminal BioSciences to Voluntarily Delist from the Toronto Stock Exchange

Canada NewsWire July 22, 2020

Liminal BioSciences Broadens R&D Pipeline With Novel Preclinical Program For Eosinophilic-Driven Diseases

Canada NewsWire July 17, 2020

Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy

Canada NewsWire July 2, 2020

Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors

Canada NewsWire June 30, 2020

Liminal BioSciences Provides Guidance Update on Certain Expected Key Milestones For 2020

Canada NewsWire June 30, 2020

The Top Healthcare Bullboards: April - June 2020

Stockhouse Editorial June 17, 2020

Liminal BioSciences to Present at Raymond James Human Health Innovation Conference

Canada NewsWire June 11, 2020

Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting Of Shareholders (AGM)

Canada NewsWire June 9, 2020

Liminal BioSciences to present at Jefferies Virtual Healthcare Conference

Canada NewsWire May 28, 2020

Liminal Biosciences Reports Q1 2020 Results

Canada NewsWire May 13, 2020

The Top Healthcare Bullboards: Jan - Mar 2020

Stockhouse Editorial March 23, 2020

Liminal BioSciences comments on Coronavirus (COVID-19)

Canada NewsWire March 22, 2020